The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BIOFIRE MOLECULAR TESTING products and services. The $209,568.78 contract, which has a period of performance through September 30, 2025, is under the VA's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits.
Biomerieux Inc., through its Biomerieux, Inc. division, will supply the VA with its proprietary diagnostic platforms, such as the BioFire FilmArray system, VITEK analyzers, and associated reagents and test kits. This contract supports the VA's healthcare operations and the need for rapid and accurate pathogen detection and identification across its facilities. The contract does not have a set-aside designation, as Biomerieux is often the sole source provider for its specialized technologies.
Generated 2/8/25, 9:03 AM